Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Juvenescence closes $100m series B round for longevity therapies

pharmaceutical-technologyAugust 20, 2019

Tag: Juvenescence , close , longevity therapies

PharmaSources Customer Service